4//SEC Filing
Meyenburg Jason Patrick 4
Accession 0000899243-21-019762
CIK 0001816736other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:45 PM ET
Size
4.7 KB
Accession
0000899243-21-019762
Insider Transaction Report
Form 4
Meyenburg Jason Patrick
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2021-05-14$9.46/sh+13,000$122,929→ 13,000 total
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001709008
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:45 PM ET
- Size
- 4.7 KB